Jarid2 is among a set of genes differentially regulated by Nkx2.5 during outflow tract morphogenesis

Developmental Dynamics

Volumn 239, Issue 7, 2010, Pages 2024-2033

  Barth, Jeremy L ^a   Clark, Christopher D ^a   Fresco, Victor M ^a   Knoll, Ellen P ^a   Lee, Benjamin ^a   Argraves, W Scott ^a   Lee, Kyu Ho ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Chromatin immunoprecipitation; Congenital heart disease; Double outlet right ventricle; Knockout; Microarray; Secondary heart field

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR NKX2.5; HOMEODOMAIN PROTEIN; JARID2 PROTEIN, MOUSE; NERVE PROTEIN; NKX2-5 PROTEIN, MOUSE; POLYCOMB REPRESSIVE COMPLEX 2; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE INTERACTION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; MESODERM; MORPHOGENESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; UPREGULATION; ANIMAL; BINDING SITE; BRANCHIAL ARCH; DNA MICROARRAY; EMBRYOLOGY; ENDODERM; GENETICS; HEART; HEART VENTRICLE; IN SITU HYBRIDIZATION; KNOCKOUT MOUSE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANIMALS; BINDING SITES; BRANCHIAL REGION; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; ENDODERM; HEART; HEART VENTRICLES; HOMEODOMAIN PROTEINS; IN SITU HYBRIDIZATION; MESODERM; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYCOMB REPRESSIVE COMPLEX 2; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 77953748302     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.22341     Document Type: Article

References (49)

1. Aerts S, Thijs G, Coessens B, Staes M, Moreau Y, De Moor B. 2003. Toucan: deciphering the cis-regulatory logic of coregulated genes. Nucleic Acids Res 31:1753-1764. (Pubitemid 36336577)
2. Aerts S, Van Loo P, Thijs G, Mayer H, de Martin R, Moreau Y, De Moor B. 2005. TOUCAN 2: the all-inclusive open source workbench for regulatory sequence analysis. Nucleic Acids Res 33:W393-W396. (Pubitemid 44529950)
3. Allen DL, Bandstra ER, Harrison BC, Thorng S, Stodieck LS, Kostenuik PJ, Morony S, Lacey DL, Hammond TG, Leinwand LL, Argraves WS, Bateman TA, Barth JL. 2009. Effects of space-flight on murine skeletal muscle gene expression. J Appl Phys 106:582-595.
4. Argraves GL, Jani S, Barth JL, Argraves WS. 2005. ArrayQuest: a web resource for the analysis of DNA microarray data. BMC Bioinformatics 6:287. (Pubitemid 41800121)
5. Biben C, Weber R, Kesteven S, Stanley E, McDonald L, Elliott DA, Barnett L, Koentgen F, Robb L, Feneley M, Harvey RP. 2000. Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2-5. Circ Res 87:888-895.
6. Brend T, Gilthorpe J, Summerbell D, Rigby PW. 2003. Multiple levels of transcriptional and post-transcriptional regulation are required to define the domain of Hoxb4 expression. Development 130:2717-2728.
7. Chen CY, Schwartz RJ. 1995. Identification of novel DNA binding targets and regulatory domains of a murine tinman homeodomain factor, nkx-2.5. J Biol Chem 270:15628-15633.
8. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. 2004. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80.
9. Goddeeris MM, Schwartz R, Klingensmith J, Meyers EN. 2007. Independent requirements for Hedgehog signaling by both the anterior heart field and neural crest cells for outflow tract development. Development 134:1593-1604.
10. Goldmuntz E, Geiger E, Benson DW. 2001. NKX2.5 mutations in patients with tetralogy of fallot. Circulation 104:2565-2568.
11. Grumet M, Mauro V, Burgoon MP, Edelman GM, Cunningham BA. 1991. Structure of a new nervous system glycoprotein, Nr-CAM, and its relationship to subgroups of neural cell adhesion molecules. J Cell Biol 113:1399-1412.
12. Habara-Ohkubo A. 1996. Differentiation of beating cardiac muscle cells from a derivative of P19 embryonal carcinoma cells. Cell Struct Funct 21:101-110. (Pubitemid 26193482)
13. Haines BP, Gupta R, Jones CM, Summerbell D, Rigby PW. 2005. The NLRR gene family and mouse development: modified differential display PCR identifies NLRR-1 as a gene expressed in early somitic myoblasts. Dev Biol 281:145-159. (Pubitemid 40719143)
14. Hogan BL. 1994. Manipulating the mouse embryo: a laboratory manual. New York: Cold Spring Harbor Press.
15. Ishii H, Baffa R, Numata SI, Murakumo Y, Rattan S, Inoue H, Mori M, Fidanza V, Alder H, Croce CM. 1999. The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors. Proc Natl Acad Sci USA 96:3928-3933. (Pubitemid 29169013)
16. Ivanova M, Dobrzycka KM, Jiang S, Michaelis K, Meyer R, Kang K, Adkins B, Barski OA, Zubairy S, Divisova J, Lee AV, Oesterreich S. 2005. Scaffold attachment factor B1 functions in development, growth, and reproduction. Mol Cell Biol 25:2995-3006.
17. Jakobsson A, Westerberg R, Jacobsson A. 2006. Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog Lipid Res 45:237-249.
18. Jay PY, Izumo S. 2002. Elucidating the molecular and genetic interactions responsible for congenital heart disease. Pediatr Res 51:127.
19. Jay PY, Harris BS, Maguire CT, Buerger A, Wakimoto H, Tanaka M, Kupershmidt S, Roden DM, Schultheiss TM, O'Brien TX, Gourdie RG, Berul CI, Izumo S. 2004. Nkx2-5 mutation causes anatomic hypoplasia of the cardiac conduction system. J Clin Invest 113:1130-1137. (Pubitemid 38544098)
20. Kasahara H, Lee B, Schott JJ, Benson DW, Seidman JG, Seidman CE, Izumo S. 2000. Loss of function and inhibitory effects of human CSX/NKX2.5 homeoprotein mutations associated with congenital heart disease. J Clin Invest 106:299-308.
21. Kasahara H, Usheva A, Ueyama T, Aoki H, Horikoshi N, Izumo S. 2001. Characterization of homo- and heterodimerization of cardiac Csx/Nkx2.5 homeoprotein. J Biol Chem 276:4570-4580.
22. Komuro I, Izumo S. 1993. Csx: a murine homeobox-containing gene specifically expressed in the developing heart. Proc Natl Acad Sci USA 90:8145-8149.
23. Lee Y, Song AJ, Baker R, Micales B, Conway SJ, Lyons GE. 2000. Jumonji, a nuclear protein that is necessary for normal heart development. Circ Res 86:932-938.
24. Lee KH, Evans S, Ruan TY, Lassar AB. 2004. SMAD-mediated modulation of YY1 activity regulates the BMP response and cardiac-specific expression of a GATA4/5/6-dependent chick Nkx2.5 enhancer. Development 131:4709-4723.
25. Li C, Wong WH. 2001. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98:31-36.
26. Li G, Margueron R, Ku M, Chambon P, Bernstein BE, Reinberg D. 2010. Jarid2 and PRC2, partners in regulating gene expression. Genes Dev 24:368-380.
27. Lints TJ, Parsons LM, Hartley L, Lyons I, Harvey RP. 1993. Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development 119:969.
28. McElhinney DB, Geiger E, Blinder J, Benson DW, Goldmuntz E. 2003. NKX2.5 mutations in patients with congenital heart disease. J Am Coll Cardiol 42:1650-1655.
29. Monzen K, Shiojima I, Hiroi Y, Kudoh S, Oka T, Takimoto E, Hayashi D, Hosoda T, Habara-Ohkubo A, Nakaoka T, Fujita T, Yazaki Y, Komuro I. 1999. Bone morphogenetic proteins induce cardiomyocyte differentiation through the mitogen-activated protein kinase kinase kinase TAK1 and cardiac transcription factors Csx/Nkx-2.5 and GATA-4. Mol Cell Biol 19:7096-7105.
30. Monzen K, Ito Y, Naito AT, Kasai H, Hiroi Y, Hayashi D, Shiojima I, Yamazaki T, Miyazono K, Asashima M, Nagai R, Komuro I. 2008. A crucial role of a high mobility group protein HMGA2 in cardiogenesis. Nat Cell Biol 10:567-574. (Pubitemid 351627376)
31. Ohno T, Nakajima K, Kojima M, Toyoda M, Takeuchi T. 2004. Modifiers of the jumonji mutation downregulate cyclin D1 expression and cardiac cell proliferation. Biochem Biophys Res Commun 317:925-929.
32. Park EJ, Watanabe Y, Smyth G, Miyagawa-Tomita S, Meyers E, Klingensmith J, Camenisch T, Buckingham M, Moon AM. 2008. An FGF autocrine loop initiated in second heart field mesoderm regulates morphogenesis at the arterial pole of the heart. Development (Cambridge, England) 135:3599-3610.
33. Pasini D, Cloos PA, Walfridsson J, Olsson L, Bukowski JP, Johansen JV, Bak M, Tommerup N, Rappsilber J, Helin K. 2010. JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. Nature 464:306-310.
34. Peng JC, Valouev A, Swigut T, Zhang J, Zhao Y, Sidow A, Wysocka J. 2009. Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell 139:1290-1302.
35. Prall OW, Menon MK, Solloway MJ, Watanabe Y, Zaffran S, Bajolle F, Biben C, McBride JJ, Robertson BR, Chaulet H, Stennard FA, Wise N, Schaft D, Wolstein O, Furtado MB, Shiratori H, Chien KR, Hamada H, Black BL, Saga Y, Robertson EJ, Buckingham ME, Harvey RP. 2007. An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation. Cell 128:947-959.
36. Richard S, Torabi N, Franco GV, Tremblay GA, Chen T, Vogel G, Morel M, Cleroux P, Forget-Richard A, Komarova S, Tremblay ML, Li W, Li A, Gao YJ, Henderson JE. 2005. Ablation of the Sam68 RNA binding protein protects mice from age-related bone loss. PLoS Genet 1:e74.
37. Rucker B, Almeida ME, Libermann TA, Zerbini LF, Wink MR, Sarkis JJ. 2007. Biochemical characterization of ecto-nucleotide pyrophosphatase/ phosphodiesterase (E-NPP, E.C. 3.1.4.1) from rat heart left ventricle. Mol Cell Biochem 306:247-254.
38. Schott JJ, Benson DW, Basson CT, Pease W, Silberbach GM, Moak JP, Maron BJ, Seidman CE, Seidman JG. 1998. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281:108-111.
39. Shen X, Kim W, Fujiwara Y, Simon MD, Liu Y, Mysliwiec MR, Yuan GC, Lee Y, Orkin SH. 2009. Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell 139:1303-1314.
40. Shirato H, Ogawa S, Nakajima K, Inagawa M, Kojima M, Tachibana M, Shinkai Y, Takeuchi T. 2009. A jumonji (Jarid2) protein complex represses cyclin D1 expression by methylation of histone H3-K9. J Biol Chem 284:733-739.
41. Takeuchi T, Yamazaki Y, Katoh-Fukui Y, Tsuchiya R, Kondo S, Motoyama J, Higashinakagawa T. 1995. Gene trap capture of a novel mouse gene, jumonji, required for neural tube formation. Genes Dev 9:1211-1222.
42. Takeuchi T, Kojima M, Nakajima K, Kondo S. 1999. jumonji gene is essential for the neurulation and cardiac development of mouse embryos with a C3H/He background. Mech Dev 86:29-38.
43. Takeuchi T, Watanabe Y, Takano-Shimizu T, Kondo S. 2006. Roles of jumonji and jumonji family genes in chromatin regulation and development. Dev Dyn 235:2449-2459.
44. Tanaka M, Chen Z, Bartunkova S, Yamasaki N, Izumo S. 1999. The cardiac homeobox "gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development 126:1269-1280.
45. Taylor KM, Nicholson RI. 2003. The LZT proteins; the LIV-1 subfamily of zinc transporters. Biochim Biophys Acta 1611:16-30.
46. Toyoda M, Shirato H, Nakajima K, Kojima M, Takahashi M, Kubota M, Suzuki-Migishima R, Motegi Y, Yokoyama M, Takeuchi T. 2003. jumonji downregulates cardiac cell proliferation by repressing cyclin D1 expression. Dev Cell 5:85-97.
47. Vadigepalli R, Chakravarthula P, Zak DE, Schwaber JS, Gonye GE. 2003. PAINT: a promoter analysis and interaction network generation tool for gene regulatory network identification. OMICS 7:235-252.
48. Waldo KL, Kumiski DH, Wallis KT, Stadt HA, Hutson MR, Platt DH, Kirby ML. 2001. Conotruncal myocardium arises from a secondary heart field. Development 128:3179-3188.
49. Wu Z, Irizarry R, Gentleman R, Murillo F, Spencer F. 2004. A Model Based Background Adjustment for Oligonucleotide Expression Arrays. J Am Stat Assoc 99:909-917.